(Q33777287)

29 July 2017

1 reference

title

Concomitant device and drug therapy: current trends, potential benefits, and adverse interactions (English)

1 reference

29 July 2017

Marchlinski FE

1

1 reference

29 July 2017

Zado ES

2

1 reference

29 July 2017

Deely MP

3

1 reference

29 July 2017

Saligan J

4

1 reference

29 July 2017

Ashar M

5

1 reference

29 July 2017

Nayak H

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Cardiology

29 July 2017

published in

1 reference

29 July 2017

volume

84

1 reference

29 July 2017

issue

9A

1 reference

29 July 2017

page(s)

69R-75R

1 reference

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Efficacy of Antitachycardia Pacing in Patients Presenting with Cardiac Arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: worldwide experience from the Guardian ATP 4210 clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Defibrillation thresholds with monophasic versus biphasic shocks delivered through a single-lead endocardial defibrillation system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Factors associated with successful implantation of nonthoracotomy defibrillation lead systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Does the initial presentation of patients with implantable defibrillator influence the outcome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Efficacy of radiofrequency catheter ablation for ventricular tachycardia in healed myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

The automatic implantable cardioverter defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Implantable defibrillation: eight years clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Long-term outcome with the automatic implantable cardioverter-defibrillator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Arrhythmias induced by device antitachycardia therapy due to diagnostic nonspecificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Effect of sotalol on ventricular fibrillation and defibrillation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Acute and Chronic Cycle Length Dependent Increase in Ventricular Pacing Threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Influence of tachycardia cycle length and antiarrhythmic drugs on pacing termination and acceleration of ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Termination of ventricular tachycardia: role of tachycardia cycle length

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

ICD-antiarrhythmic drug and ICD-pacemaker interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Interactions between implantable cardioverter-defibrillators and class III agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Interactions between drugs and devices: experimental and clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Effects of flecainide on defibrillation thresholds in the anesthetized dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Effects of chronic amiodarone therapy on defibrillation threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900705-5

10.1016/S0002-9149(99)00705-5

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference